FOXP3 and cancer: et al, conditional deletion or C646 pharmacologic inhibition of p300 in Foxp3+ Treg cells increased T cell receptor-induced apoptosis in Treg cells, leading to limited AE17 tumor growth in immunocompetent mice, indicating that C646 is a promising therapeutic candidate for cancer immunotherapy 34.